AC Immune’s Tau-targeting therapy shows promise in early Alzheimer’s trial
30th September 2025 Uncategorised 0
Early-stage study reveals strong immune response and safety profile for ACI-35.030

More: AC Immune’s Tau-targeting therapy shows promise in early Alzheimer’s trial
Source: News
